
    
      Detailed Description : The study was conducted as an open-label, randomized, single-dose,
      2-way crossover, relative bioavailability study performed on 30 healthy adult male
      volunteers. A total of 30 subjects completed the clinical phase of the study. Single oral 40
      mg doses were separated by a washout period of 7 days.
    
  